Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD247 antibody (Biotin)

The Rabbit Monoclonal anti-CD247 antibody has been validated for FACS, IF and ICC. It is suitable to detect CD247 in samples from Human.
Catalog No. ABIN7770856

Quick Overview for Recombinant CD247 antibody (Biotin) (ABIN7770856)

Target

See all CD247 Antibodies
CD247 (CD247 Molecule (CD247))

Antibody Type

Recombinant Antibody

Reactivity

  • 89
  • 38
  • 15
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 72
  • 14
  • 5
  • 1
Rabbit

Clonality

  • 61
  • 31
Monoclonal

Conjugate

  • 52
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
This CD247 antibody is conjugated to Biotin

Application

  • 58
  • 42
  • 36
  • 18
  • 15
  • 15
  • 9
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone

SR2324
  • Purpose

    Conjugated CD3 zeta Rabbit mAb

    Specificity

    CD3 zeta Antibody detects endogenous levels of total CD3 zeta

    Purification

    Affinity-chromatography

    Immunogen

    A synthesized peptide derived from human CD3 zeta
  • Application Notes

    working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000

    Restrictions

    For Research Use only
  • Buffer

    Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light!

    Storage

    4 °C

    Storage Comment

    Store at 4°C in dark for 6 months
  • Target

    CD247 (CD247 Molecule (CD247))

    Alternative Name

    CD3 zeta

    Background

    CD3-zeta, T-cell receptor T3 zeta chain, T3Z, TCRZ, CD247,

    Molecular Weight

    kDa

    UniProt

    P20963

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Ubiquitin Proteasome Pathway
You are here:
Chat with us!